换一批A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer.
第一作者：
Vergote I
作者：
关键词
AdultAgedAntimetabolitesAntineoplasticChi-Square DistributionDNA-Binding ProteinsDisease-Free SurvivalDouble-Blind MethodDrug Administration ScheduleDrug ResistanceNeoplasmEndonucleasesFemaleFolic Acid AntagonistsGene ExpressionGlutamatesGuanineHumansKaplan-Meiers EstimateMembrane Transport ProteinsMiddle AgedOvarian NeoplasmsPeritoneal NeoplasmsPlatinum CompoundsPrognosisSurvival RateTreatment Outcome
发布时间
2013-11-20
- 浏览0
![European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)](https://cdnimg.med.wanfangdata.com.cn/imgs/qkindeximg/N2007EPST0000700/N2007EPST0000700.jpg)
European journal of cancer
1415-1423页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
